B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV
Johannes F. Scheid, Christopher O. Barnes, Basak Eraslan, Andrew Hudak, Jennifer R. Keeffe, Lisa A. Cosimi, Eric Brown, Frauke Muecksch, Yiska Weisblum, Shuting Zhang, Toni Delorey, Ann E. Woolley, Fadi Ghantous, Sung‐Moo Park, Devan Phillips, Betsabeh Khoramian Tusi, Kathryn E. Huey‐Tubman, Alexander A. Cohen, Priyanthi N.P. Gnanapragasam, Kara M. Rzasa, Theodora Hatziioanno, Michael A. Durney, Xiebin Gu, Takuya Tada, Nathaniel R. Landau, Anthony P. West, Orit Rozenblatt–Rosen, Michael S. Seaman, Lindsey R. Baden, Daniel B. Graham, Jacques Deguine, Paul D. Bieniasz, Aviv Regev, Deborah T. Hung, Pamela J. Björkman, Ramnik J. Xavier
Topics & Concepts
BiologyImmunogenVirologyMonoclonal antibodyNeutralizationAntibodyEpitopeSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CoronavirusRNAAvidityB cellMolecular biologyGeneCoronavirus disease 2019 (COVID-19)GeneticsVirusPathologyInfectious disease (medical specialty)DiseaseMedicineSARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesImmunotherapy and Immune Responses